Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
bloomberg.com
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
You are viewing a single comment
No comments yet. You could be first!